Oaktree Acquisition Corp. III Life Sciences

OACCW | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.88

+$0.01 (+1.15%)

May 20, 2026, 11:02 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.15%

(1D)

Rating

Updated: Apr 27, 2026

24.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $21.61M

1D Range

0.67 0.88

52W Range

0.67 0.99

Valuation (TTM)

PE 3.03

PB -2.99

EV/EBITDA -16.84

Valuation (NTM)

Forward PE N/A

Forward PEG N/A

Price Target N/A

Cash Flow

FCF Yield -2.0%

SBC Adj. FCF Yield -2.0%

SBC Impact N/A

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y N/A | N/A

FCF 3Y | 5Y N/A | N/A

Returns

ROA 3.4%

ROE 4.9%

ROIC -0.6%

Financial Health

Net Cash

$1.28M

Current Ratio 0.87

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or simil...

Sector Financial Services

Industry Shell Companies

Employees n/a

IPO Date Oct 5, 2025

Website www.oaktreeacquisitioncorp.com/oac-iii

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.